Europe
Novartis reported its full-year financials this week for 2021, and overall, the news was good. Of concern, however, is the company’s Sandoz generics unit.
A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell therapy are still in remission 10 years later.
Up to 40% of AD patients were found to have Lewy Bodies in their brain after succumbing to the disease.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
This week, two biotechnology firms announced new leadership, David Nassif, J.D., and Christophe Bourdon.
You are what you eat, and your defense system notices that.
What makes a candidate attractive? For Deschoolmeester, three critical elements stand out: pragmatism, creativity and collaboration.
Researchers are expressing concern about a subvariant of Omicron dubbed BA.2 that appears to be tearing through Denmark. For that and more COVID-19 news, continue reading.
Oxford BioMedica and Homology Medicines have formed a symbiotic partnership to launch a full scope AAV manufacturing and innovation business.
The FDA had accepted the sBLA in September 2021 under priority review status.
PRESS RELEASES